Trademark247.com - Trademark Search Results

Showing 1-20 of 52 results

Mark Name	Mark Description
DERMAGEN Owned by: OSIRIS THERAPEU... Filed on: 03-14-1995 Status: Abandoned-No Statement of...	pharmaceutical preparations for use in the partial or complete differentiation of mesenchymal progenitor cells or partially differentiated mesen	View Details Monitor Mark Create New Watchlist
DERMAGEN Owned by: OSIRIS THERAPEU... Filed on: 06-18-1999 Status: Abandoned-No Statement of...	Pharmaceutical preparation for use in the partial or complete differentiation of mesenchymal progenitor cells or partially differentiation mesen	View Details Monitor Mark Create New Watchlist
Owned by: VIACORD LLC Filed on: 08-22-1995 Status: Cancelled-Section 8	blood products, namely cord blood and peripheral blood stem and progenitor cells	View Details Monitor Mark Create New Watchlist
RIGHT NOW Owned by: OSIRIS THERAPEU... Filed on: 04-23-2007 Status: Cancelled-Section 8	Chemical or biological agents which cause progenitor cells to differentiate into cartilage tissue lineage cells or which cause progenitor cells	View Details Monitor Mark Create New Watchlist
THE LEADER IN CORD BLOOD ... Owned by: VIACORD, INC. Filed on: 06-11-1997 Status: Abandoned-Failure to Resp...	blood products, namely, cord blood and peripheral blood stem and progenitor cells	View Details Monitor Mark Create New Watchlist
MYOPOIETIN Owned by: OSIRIS THERAPEU... Filed on: 03-13-1995 Status: Abandoned-No Statement of...	chemical or biological agents which cause progenitor cells to differentiate into muscle tissue lineage	View Details Monitor Mark Create New Watchlist
MYOPOIETIN Owned by: OSIRIS THERAPEU... Filed on: 01-12-1999 Status: Abandoned-Failure to Resp...	Chemical or biological agents which cause progenitor cells to differentiate into muscle tissue lineage	View Details Monitor Mark Create New Watchlist
OSTEOPOIETIN Owned by: OSIRIS THERAPEU... Filed on: 03-13-1995 Status: Abandoned-No Statement of...	chemical or biological agents which cause progenitor cells to differentiate into bone tissue lineage	View Details Monitor Mark Create New Watchlist
OSTEOPOIETIN Owned by: OSIRIS THERAPEU... Filed on: 01-12-1999 Status: Abandoned-Failure to Resp...	Chemical or biological agents which cause progenitor cells to differentiate into bone tissue lineage	View Details Monitor Mark Create New Watchlist
COLLAGEL Owned by: OSIRIS THERAPEU... Filed on: 07-30-1996 Status: Abandoned-No Statement of...	formulations of biodegradable materials combined with progenitor cells to form new tissue in vivo or in vitro for medical use	View Details Monitor Mark Create New Watchlist
ADIPOGEN Owned by: OSIRIS THERAPEU... Filed on: 07-30-1996 Status: Abandoned-No Statement of...	chemical or biological agents which cause progenitor cells to be differentiated into fat tissue lineage cells for medical use	View Details Monitor Mark Create New Watchlist
CHONDROGEN Owned by: OSIRIS THERAPEU... Filed on: 03-13-1995 Status: Abandoned-No Statement of...	chemical or biological agents which cause progenitor cells to differentiate into cartilage tissue lineage cells	View Details Monitor Mark Create New Watchlist
CHONDROGEN Owned by: OSIRIS THERAPEU... Filed on: 02-03-2000 Status: Abandoned-No Statement of...	Chemical or biological agents which cause progenitor cells to differentiate into cartilage tissue lineage cells	View Details Monitor Mark Create New Watchlist
CHONDROGEN Owned by: MESOBLAST INTER... Filed on: 11-19-2008 Status: Cancelled-Section 8	Progenitor cells capable of differentiating into cartilage tissue cells for use in therapeutic, medical or clinical cellular therapies	View Details Monitor Mark Create New Watchlist
CHONDROGEN Owned by: OSIRIS THERAPEU... Filed on: 04-15-2004 Status: Abandoned-No Statement of...	CHEMICAL OR BIOLOGICAL AGENTS WHICH CAUSE PROGENITOR CELLS TO DIFFERENTIATE INTO CARTILAGE TISSUE LINEAGE CELLS	View Details Monitor Mark Create New Watchlist
DERMANEXIN Owned by: OSIRIS THERAPEU... Filed on: 07-30-1996 Status: Abandoned-No Statement of...	chemical or biological agents for medical use which cause tissue-forming progenitor cells to commit into or produce differentiated dermis tissue	View Details Monitor Mark Create New Watchlist
ADIPOPOIETIN Owned by: OSIRIS THERAPEU... Filed on: 07-30-1996 Status: Abandoned-No Statement of...	pharmaceuticals preparations for use in the partial or complete differentiation of mesenchymal progenitor cells or partially differentiated mese	View Details Monitor Mark Create New Watchlist
PROMESYN Owned by: OSIRIS THERAPEU... Filed on: 07-30-1996 Status: Abandoned-Failure to Resp...	chemical or biological agents for medical use which cause tissue-forming progenitor cells to proliferate in vitro or in vivo	View Details Monitor Mark Create New Watchlist
MYOGEN Owned by: OSIRIS THERAPEU... Filed on: 03-13-1995 Status: Abandoned-Failure to Resp...	chemical or biological agents which cause progenitor cells to differentiate into muscle tissue	View Details Monitor Mark Create New Watchlist
ADIPONEXIN Owned by: OSIRIS THERAPEU... Filed on: 07-30-1996 Status: Abandoned-No Statement of...	chemical or biological agents which cause tissue-forming progenitor cells to commit into or produce differentiated adipose tissue in vitro or in	View Details Monitor Mark Create New Watchlist

Preparing summary view, please wait...

Owner Summary

This report includes a summary of your search results. The 'Marks Matched' column indicates the number of results that match a particular trademark owner, It does not include all of their other marks.

Primary Classification Summary

Status Summary

File Year Summary

Registration Statistics

Quick Links

Updated Daily